251087-38-4

Name	FRATIDE
CAS	251087-38-4
Molecular Formula	C192H327N67O60
MDL Number	MFCD04974166

Synonyms

FRATIDE M.W. 4534.11 C192H327N67O60 L-Glutamine, L-seryl-L-glutaminyl-L-prolyl-L-a-glutamyl-L-threonyl-L-arginyl-L-threonylglycyl-L-a-aspartyl-L-a-aspartyl-L-a-aspartyl-L-prolyl-L-histidyl-L-arginyl-L-leucyl-L-leucyl-L-glutaminyl-L-glut aminyl-L-leucyl-L-valyl-L-leucyl-L-serylglycyl-L-asparaginyl-L-leucyl-L-isoleucyl-L-lysyl-L-a-glut L-Glutamine, L-seryl-L-glutaminyl-L-prolyl-L-a-glutamyl-L-threonyl-L-arginyl-L-threonylglycyl-L-a-aspartyl-L-a-aspartyl-L-a-aspartyl-L-prolyl-L-histidyl-L-arginyl-L-leucyl-L-leucyl-L-glutaminyl-L-glut aminyl-L-leucyl-L-valyl-L-leucyl-L-serylglycyl-L-asparaginyl-L-leucyl-L-isoleucyl-L-lysyl-L-a-glutamyl-L-alanyl-L-valyl-L-arginyl-L-arginyl-L-leucyl-L-histidyl-L-seryl-L-arginyl-L-arginyl-L-leucyl- (9 CI) L-Seryl-L-glutaminyl-L-prolyl-L-alpha-glutamyl-L-threonyl-L-arginyl-L-threonylglycyl-L-alpha-aspartyl-L-alpha-aspartyl-L-alpha-aspartyl-L-prolyl-L-histidyl-L-arginyl-L-leucyl-L-leucyl-L-glutaminyl-L-glutaminyl-L-leucyl-L-valyl-L-leucyl-L-serylglycyl-L-asparaginyl-L-leucyl-L-isoleucyl-L-lysyl-L-alpha-glutamyl-L-alanyl-L-valyl-L-arginyl-L-arginyl-L-leucyl-L-histidyl-L-seryl-L-arginyl-L-arginyl-L-leucyl-L-glutamine

show less show more

Chemical Properties

storage temp.	Desiccate at -20°C
solubility	Soluble in DMSO
form	solid
color	White lyophilised
Sequence	Ser-Gln-Pro-Glu-Thr-Arg-Thr-Gly-Asp-Asp-Asp-Pro-His-Arg-Leu-Leu-Gln-Gln-Leu-Val-Leu-Ser-Gly-Asn-Leu-Ile-Lys-Glu-Ala-Val-Arg-Arg-Leu-His-Ser-Arg-Arg-Leu-Gln

Hazard Information

Description

Inhibitor of glycogen synthase kinase-3 (GSK-3); derived from FRAT1, the mammalian version of GSK-3-binding protein. Binds to GSK-3, inhibiting its interaction with axin, and also blocks GSK-3-catalyzed phosphorylation of axin and β-catenin. Does not affect GSK-3-mediated phosphorylation of glycogen synthase or eIF2B.

Uses

FRATtide is a peptide derived from the GSK-3 binding protein that inhibits the phosphorylation of Axin and β-catenin. FRATtide inhibits GSK-3 binding to Axin[1].

References

[1] Bax B, et al. The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation. Structure. 2001 Dec;9(12):1143-52. DOI:10.1016/s0969-2126(01)00679-7

Supplier

3B Pharmachem (Wuhan) International Co.,Ltd.

Telephone 18930552037

Websitehttps://www.chemicalbook.com/ShowSupplierProductsList13285/0_EN.htm

Hangzhou Peptidego Biotech Co.,Ltd.

Telephone0571-87213919 15967184799

Websitehttp://peptidego.com

Hangzhou Sinoda Pharmaceutical Technology Co. LTD

Telephone0571-87213919 17306812703

Websitehttps://www.chemicalbook.com/ShowSupplierProductsList1355681/0_EN.htm

Shanghai HongTide Biotechnology Co.,Ltd.

Telephone15318089928

Websitehttps://www.hongtide.com/index.php

Fuan Bio

Telephone 15002819872

Websitehttp://fuanbio.com

Related Products

36635-61-7 2999-46-4

645-96-5 7188-38-7

14542-93-9 39687-95-1

2769-64-4

PROMPT×

PROMPT
The What'sApp is temporarily not supported in mainland China

Cancel

Determine

Send Inquriy